Gene · 7832
Papers2,269
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,269
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Non-Coding RNAs and Gut Microbiota in the Pathogenesis of Cardiac Arrhythmias: The Latest Update. | Genes (Basel) | 2023 | 37761875 | PubTator, text mining | PubMed |
| Thymoquinone Potentially Modulates the Expression of Key Onco- and Tumor Suppressor miRNAs in Prostate and Colon Cancer Cell Lines: Insights from PC3 and HCT-15 Cells. | Genes (Basel) | 2023 | 37761870 | PubTator, text mining | PubMed |
| TRIM6: An Upregulated Biomarker with Prognostic Significance and Immune Correlations in Gliomas. | Biomolecules | 2023 | 37759698 | PubTator, text mining | PubMed |
| A New Understanding of Long Non-Coding RNA in Hepatocellular Carcinoma-From m6A Modification to Blood Biomarkers. | Cells | 2023 | 37759495 | PubTator, text mining | PubMed |
| Btg2 Promotes Focal Segmental Glomerulosclerosis via Smad3-Dependent Podocyte-Mesenchymal Transition. | Adv Sci (Weinh) | 2023 | 37749872 | PubTator, text mining | PubMed |
| INHAT subunit SET/TAF-Iβ regulates PRC1-independent H2AK119 mono-ubiquitination via E3 ligase MIB1 in colon cancer. | NAR Cancer | 2023 | 37746636 | PubTator, text mining | PubMed |
| Editorial: Epigenetic insights into diagnostic and therapeutic applications. | Front Oncol | 2023 | 37746270 | PubTator, text mining | PubMed |
| Characterization and therapeutic perspectives of differentiation-inducing therapy in malignant tumors. | Front Genet | 2023 | 37745860 | PubTator, text mining | PubMed |
| KAS-Analyzer: a novel computational framework for exploring KAS-seq data. | Bioinform Adv | 2023 | 37745002 | PubTator, text mining | PubMed |
| miRNAs and Multiple Myeloma: Focus on the Pathogenesis, Prognosis, and Drug Resistance. | Technol Cancer Res Treat | 2023 | 37728167 | PubTator, text mining | PubMed |
| To identify biomarkers associated with the transfer of diabetes combined with cancer in human genes using bioinformatics analysis. | Medicine (Baltimore) | 2023 | 37713834 | PubTator, text mining | PubMed |
| Key role of exosomes derived from M2 macrophages in maintaining cancer cell stemness (Review). | Int J Oncol | 2023 | 37711063 | PubTator, text mining | PubMed |
| miR-92a-3p regulates cisplatin-induced cancer cell death. | Cell Death Dis | 2023 | 37704611 | PubTator, text mining | PubMed |
| The early-phase transcriptome and the clinical efficacy analysis in three modes of subcutaneous immunotherapy for allergic rhinitis. | World Allergy Organ J | 2023 | 37701629 | PubTator, text mining | PubMed |
| Interactions between microglia and glioma in tumor microenvironment. | Front Oncol | 2023 | 37700840 | PubTator, text mining | PubMed |
| SARS-CoV-2 infection induces a long-lived pro-inflammatory transcriptional profile. | Genome Med | 2023 | 37700317 | PubTator, text mining | PubMed |
| Chemical-induced phase transition and global conformational reorganization of chromatin. | Nat Commun | 2023 | 37689690 | PubTator, text mining | PubMed |
| Metastasis organotropism in colorectal cancer: advancing toward innovative therapies. | J Transl Med | 2023 | 37689664 | PubTator, text mining | PubMed |
| Integrated signaling and transcriptome analysis reveals Src family kinase individualities and novel pathways controlled by their constitutive activity. | Front Immunol | 2023 | 37680627 | PubTator, text mining | PubMed |
| Should I stay or should I go? Spatio-temporal control of cellular anchorage by hematopoietic factors orchestrates tumor metastatic cascade. | Mol Cancer | 2023 | 37679813 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7832/papers?page=11